反応式
[Br:1][C:2]1[CH:3]=[C:4]2[CH2:13][CH2:12][N:11]3[C:5]2=[C:6]([CH:26]=1)[C:7]([N:19]1[CH2:24][CH2:23][N:22]([CH3:25])[CH2:21][CH2:20]1)=[N:8][C:9]1[CH:17]=[C:16]([Br:18])[CH:15]=[CH:14][C:10]=13>C(Cl)(Cl)Cl.[O-2].[O-2].[Mn+4]>[Br:1][C:2]1[CH:3]=[C:4]2[CH:13]=[CH:12][N:11]3[C:5]2=[C:6]([CH:26]=1)[C:7]([N:19]1[CH2:20][CH2:21][N:22]([CH3:25])[CH2:23][CH2:24]1)=[N:8][C:9]1[CH:17]=[C:16]([Br:18])[CH:15]=[CH:14][C:10]=13参加物
4
実験手順
A mixture 4,9-dibromo-6-(4-methyl-1-piperazinyl)-1,2-dihydrobenzo[b]pyrrolo[3,2,1-jk][1,4]-benzodiazepine (4.5 g, 9.45 mmoles) and manganese(IV) dioxide (7.0 g) in chloroform (150 ml) was heated under reflux for 3.5 hours. An additional 4.5 g of manganese dioxide was added. The reaction mixture was stirred overnight at room temperature. The mixture was filtered through celite and the filtrate was concentrated. The residue was purified by flash chromatography over a silica gel column (140 gm), eluted with 2% methanol:98% dichloromethane (2 l). The appropriate fractions were collected and evaporated. Crystallization of the residue from isopropanol (10 ml) yielded 3.37 g (75%) of product, mp 158°-159° C.
後処理
- temperatureunder reflux for 3.5 hours
- filtrationThe mixture was filtered through celite
- concentrationthe filtrate was concentrated
- customThe residue was purified by flash chromatography over a silica gel column (140 gm)
- washeluted with 2% methanol
- customThe appropriate fractions were collected
- customevaporated
- customCrystallization of the residue from isopropanol (10 ml)
出典と根拠
- ORDレコード
- ord-a336759d16894dc48e61e823dcf0ae71
- 出典データセット
- uspto-grants-1988_02
- 特許番号
- US04723007
関連ノート
読み込み中…